Task: Answer the multiple choice question.
Question: Which drug exhibits a 3.525\% human ether-à-go-go related gene (hERG) inhibition at a concentration of 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a: Cl.NS(=O)(=O)c1cccc(N2CCNCC2)c1
b: N#CCCN(C(=O)CSc1ncccn1)c1ccc2c(c1)OCCO2
c: Cc1cccc(-n2c(Cc3cc(=O)[nH]c(=O)[nH]3)nnc2SCC(=O)NCC2CCCO2)c1
Answer: b. N#CCCN(C(=O)CSc1ncccn1)c1ccc2c(c1)OCCO2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
N#CCCN(C(=O)CSc1ncccn1)c1ccc2c(c1)OCCO2
N#CCCN(C(=O)CSc1ncccn1)c1ccc2c(c1)OCCO2
N-(2-cyanoethyl)-N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-pyrimidin-2-ylsulfanylacetamide